Engineering immunoglobulin genes for novel Tuberculosis vaccine production in plants
Tuberculosis is ranked in the top ten leading causes of death from an infectious disease. In 2015, an estimated 10.4 million people developed TB and 1.8 million died from the disease. There is a long-standing vaccine against TB, called BCG, but its ineffectiveness highlights the need for a new novel...
| Main Author: | |
|---|---|
| Published: |
St George's, University of London
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.753991 |